Xu Hong, Shi Weifeng, Liu Hong, Chai Shasha, Xu Jindi, Tu Qingyu, Xu Jinwei, Zhuang Wei
Department of Orthopaedics, Hangzhou Xiaoshan Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang Province, China.
Zhejiang Chinese Medical University, Zhejiang Province, China.
BMC Musculoskelet Disord. 2025 Mar 11;26(1):236. doi: 10.1186/s12891-025-08474-6.
Knee osteoarthritis (KOA) is a common joint disorder, and intra-articular injections of hyaluronic acid (HA) or platelet-rich plasma (PRP) are frequently employed therapeutic interventions. However, there remains controversy regarding their efficacy. This systematic review aims to compare the effectiveness and safety of HA and PRP through a meta-analysis, with the objective of identifying the optimal treatment protocol for KOA and enhancing its management.
Randomized controlled trials evaluating the clinical outcomes of patients receiving intra-articular injections of either HA or PRP were included as eligible studies. Two independent investigators assessed the selected studies and evaluated their risk of bias. Primary outcome measures included the Visual Analog Scale (VAS) score, the Western Ontario and McMaster Universities Arthritis Index (WOMAC) score, and other relevant assessment indices. Dichotomous variables were analyzed using risk ratios (RR) with 95% confidence intervals (CI). Data analysis was conducted using RevMan software (version 5.3).
A total of forty-two randomized controlled trials were included in this meta-analysis. No significant differences were observed between the patient populations in the two groups. The analysis demonstrated that PRP resulted in lower VAS and WOMAC scores compared to HA. Additionally, PRP exhibited superior performance across other evaluation indices. Notably, the incidence of adverse events was higher in the PRP group; however, all reported complications were mild.
Based on the current evidence, intra-articular injection of PRP appears to be more effective than HA for the treatment of KOA, as indicated by the analysis of VAS, WOMAC scores, and other evaluation indices.
Retrospectively registered.
膝关节骨关节炎(KOA)是一种常见的关节疾病,关节腔内注射透明质酸(HA)或富血小板血浆(PRP)是常用的治疗干预措施。然而,它们的疗效仍存在争议。本系统评价旨在通过荟萃分析比较HA和PRP的有效性和安全性,以确定KOA的最佳治疗方案并加强其管理。
评估接受关节腔内注射HA或PRP患者临床结局的随机对照试验被纳入合格研究。两名独立研究人员评估所选研究并评估其偏倚风险。主要结局指标包括视觉模拟量表(VAS)评分、西安大略和麦克马斯特大学骨关节炎指数(WOMAC)评分以及其他相关评估指标。二分变量使用风险比(RR)和95%置信区间(CI)进行分析。使用RevMan软件(5.3版)进行数据分析。
本荟萃分析共纳入42项随机对照试验。两组患者人群之间未观察到显著差异。分析表明,与HA相比,PRP导致更低的VAS和WOMAC评分。此外,PRP在其他评估指标上表现更优。值得注意的是,PRP组不良事件的发生率更高;然而,所有报告的并发症均为轻度。
根据目前的证据,通过对VAS、WOMAC评分和其他评估指标的分析表明,关节腔内注射PRP治疗KOA似乎比HA更有效。
回顾性注册。